Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Norepinephrine and Genistein

supplement:

Genistein

Research Papers that Mention the Interaction

The src kinase inhibitors genistein or PP2 normalised the increased contraction and the increased calcium release evoked by noradrenaline in cultured arteries.
Journal of Vascular Research  •  2009  |  View Paper
4 Genistein but not daidzein enhanced the positive inotropic effect and the increase in Ca2+ transients induced by NE via β‐adrenoceptors, while the enhancing effect of genistein was abolished by the protein tyrosine phosphatase inhibitor vanadate.
In addition, genistein inhibits the negative inotropic effect of ET‐1 induced by crosstalk with NE through a PTK‐unrelated mechanism.
British journal of pharmacology  •  2005  |  View Paper
In addition, genistein could reduce the contractile responses of NA , KCl and CaCl2, and shift their cumulative concentration-response curves rightward. (
In calcium-free solution containing 0.01 mmol/L egtazic acid (EGTA), genistein inhibited not only the first phase contraction induced by noradrenaline (NA), but also the second contraction induced by CaCl2.
Acta pharmacologica Sinica  •  2004  |  View Paper
Genistein , although having no effect on acute NE-induced contraction, concentration-dependently inhibited prolonged NE constriction.
American journal of physiology. Heart and circulatory physiology  •  2003  |  View Paper
Genistein (1 mg/kg) and daidzein (1 mg/kg) reduced contractile response to NA in vascular tissue, but only genistein was able to inhibit hyporesponsiveness to NA, relaxation to l‐arg, increase in nitrite plasma levels, and iNOS expression produced by endotoxin.
Journal of cardiovascular pharmacology  •  2003  |  View Paper
Contractions induced by both noradrenaline and the alpha 2-adrenoceptor-selective agonist UK14304 (5-bromo-6-[2-imidazolin-2-yl-amino]-quinoxaline) were fully inhibited by genistein , with the latter responses being more sensitive.
European journal of pharmacology  •  1996  |  View Paper
Genistein (10 microM) reduced the amplitude of the contraction evoked by noradrenaline (0.1-10 microM) or angiotensin II (1-100 nM).
Pulmonary pharmacology  •  1996  |  View Paper
The treatment with noradrenaline induced the tyrosine phosphorylation of specific substrates in lysates derived from PC Cl3 cells, an effect inhibited by genistein pretreatment.
The tyrosine kinases inhibitor genistein completely abolishes the plateau upon noradrenaline withdrawal.
Biochemical and biophysical research communications  •  1995  |  View Paper